| Literature DB >> 31144479 |
Ying Yu1, Yi Lyu2, Lin Jin1, Liying Xu1, Huilin Wang1, Yan Hu1, Yun Ren1, Kefang Guo1.
Abstract
OBJECTIVE: To explore the prognostic factors for permanent neurological dysfunction (PND) after total aortic arch replacement with regional cerebral oxygen saturation (rSO2 ) monitoring.Entities:
Keywords: deep hypothermic circulatory arrest; permanent neurological dysfunction; prognostic factors; regional cerebral oxygen saturation monitoring; total aortic arch replacement
Mesh:
Year: 2019 PMID: 31144479 PMCID: PMC6625482 DOI: 10.1002/brb3.1309
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Overall neurologic outcomes
| Outcome | No. (%) |
|---|---|
| All‐cause mortality | 15 (15.3) |
| Neurological dysfunction | |
| NND | 56 (57.1) |
| TND | 29 (29.6) |
| PND | 13 (13.3) |
| Motor or sensory disorder | |
| Temporary disorder | 7 (7.1) |
| Permanent disorder | 8 (8.2) |
| Consciousness disorder | |
| Temporary disorder | 33 (33.7) |
| Permanent disorder | 3 (3.1) |
| Consciousness outcome | |
| Clear consciousness | 62 (63.3) |
| Delirium | 21 (21.4) |
| Lethargy | 3 (3.1) |
| Coma | 12 (12.2) |
Abbreviations: NND, nonneurological dysfunction; TND, transient neurological dysfunction; PND, permanent neurological dysfunction.
Preoperative demographics, patient‐related factors, laboratory variables and characterizing intraoperative factors in patients with NND, TND or PNDa
| Variable | NND ( | TND ( | PND ( |
|
|---|---|---|---|---|
| Male | 38 (67.9%) | 26 (89.7%) | 10 (76.9%) | 0.085 |
| Age (years) | 50.48 ± 10.6 | 47.52 ± 12.83 | 56.54 ± 9.32 | 0.058 |
| BMI (kg/m2) | 24.42 ± 3.54 | 24.27 ± 3.16 | 23.95 ± 3.07 | 0.902 |
| Marfan Syndrome | 8 (14.3%) | 3 (10.3%) | 0 (0.0%) | 0.165 |
| Hypertension | 40 (71.4%) | 22 (75.9%) | 11 (84.6%) | 0.605 |
| Diabetes | 6 (10.7%) | 5 (17.2%) | 2 (15.4%) | 0.686 |
| LVEF (%) | 61.13 ± 15.86 | 60.38 ± 18.80 | 59.69 ± 18.49 | 0.956 |
| NT‐proBNP(pg/ml) | 437.82 ± 715.29 | 544.10 ± 690.21 | 465.16 ± 667.79 | 0.803 |
| Hb (g/L) | 124.02 ± 16.39 | 129.24 ± 17.77 | 130.15 ± 16.39 | 0.277 |
| WBC (×109/L) | 10.76 ± 14.59 | 9.99 ± 4.66 | 12.52 ± 4.10 | 0.804 |
| PLT(×109/L) | 231.68 ± 95.14 | 197.90 ± 58.04 | 158.62 ± 65.01 | 0.011 |
| Alb (g/L) | 37.54 ± 6.28 | 40.38 ± 5.17 | 39.38 ± 6.74 | 0.112 |
| ALT (U/L) | 33.46 ± 36.58 | 39.41 ± 79.87 | 30.17 ± 23.83 | 0.838 |
| AST (U/L) | 29.88 ± 17.80 | 35.03 ± 71.45 | 54.00 ± 64.66 | 0.274 |
| BUN (mmol/L) | 5.90 ± 1.87 | 6.57 ± 2.29 | 6.42 ± 1.67 | 0.312 |
| Scr (μmol/L) | 83.23 ± 27.24 | 90.93 ± 43.77 | 78.77 ± 25.83 | 0.458 |
| INR | 1.21 ± 1.66 | 0.98 ± 0.21 | 1.00 ± 0.32 | 0.691 |
| Mean rSO2 basal value | 64.34 ± 8.84 | 67.05 ± 12.01 | 62.23 ± 8.55 | 0.295 |
| ΔrSO2min (%) | ||||
| Throughout operation | 79.37 ± 12.03 | 82.62 ± 12.88 | 67.38 ± 19.51 | 0.004 |
| During SACP | 90.00 ± 17.77 | 94.99 ± 15.61 | 76.95 ± 19.71 | 0.010 |
| Throughout CPB | 80.76 ± 12.67 | 84.79 ± 12.62 | 70.67 ± 18.49 | 0.009 |
| During hemostasis | 89.53 ± 12.47 | 89.96 ± 20.23 | 78.89 ± 16.78 | 0.086 |
| Intraoperative factors | ||||
| LNT in DHCA(°C) | 18.79 ± 1.34 | 18.28 ± 1.14 | 19.02 ± 1.17 | 0.122 |
| Surgery time (min) | 333.46 ± 67.97 | 343.48 ± 67.70 | 360.62 ± 60.16 | 0.401 |
| SACP time (min) | 36.86 ± 11.71 | 39 ± 13.54 | 42.08 ± 9.55 | 0.342 |
| CPB time (min) | 165.38 ± 34.54 | 172.31 ± 39.35 | 165.08 ± 22.99 | 0.664 |
| Hemostasis time (min) | 107.32 ± 29.15 | 114.86 ± 26.01 | 126.23 ± 29.71 | 0.083 |
Abbreviations: NND, nonneurological dysfunction; TND, transient neurological dysfunction; PND, permanent neurological dysfunction; BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; Hb, hemoglobin; WBC, white blood cell count; Alb, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Scr, serum creatinine; INR, international normalized ratio; SACP, selective antegrade cerebral perfusion; CPB, cardiopulmonary bypass; LNT, lowest nasopharyngeal temperature; DHCA, deep hypothermic circulatory arrest. Values are presented as the mean ± SD or number (percentage).
LSD test was used for post hoc analysis.
Logistic regression model explaining probability difference between PND and NND
| Model by duration | Parameter | OR value | 95% CI |
|
|---|---|---|---|---|
| Whole operation | Age | 1.099 | (1.005–1.202) | 0.039 |
| ΔrSO2min | 0.925 | (0.871–0.982) | 0.011 | |
| Platelet | 0.988 | (0.978–0.999) | 0.034 | |
| Hemostasis time | 1.043 | (1.009–1.078) | 0.014 | |
| Female | 0.245 | (0.039–1.554) | 0.135 | |
| SACP | Age | 1.094 | (0.998–1.199) | 0.055 |
| ΔrSO2min | 0.927 | (0.872–0.986) | 0.015 | |
| Platelet | 0.984 | (0.973–0.996) | 0.009 | |
| Hemostasis time | 1.047 | (1.010–1.086) | 0.012 | |
| Female | 0.202 | (0.029–1.429) | 0.109 | |
| CPB | Age | 1.088 | (1.000–1.185) | 0.050 |
| ΔrSO2min | 0.936 | (0.882–0.993) | 0.028 | |
| Platelet | 0.988 | (0.977–0.999) | 0.025 | |
| Hemostasis time | 1.038 | (1.005–1.071) | 0.022 | |
| Female | 0.248 | (0.038–1.615) | 0.145 | |
| Hemostasis | Age | 1.075 | (0.991–1.165) | 0.082 |
| ΔrSO2min | 0.943 | (0.894–0.996) | 0.034 | |
| Platelet | 0.988 | (0.977–0.999) | 0.029 | |
| Hemostasis time | 1.042 | (1.010–1.076) | 0.011 | |
| Female | 0.325 | (0.054–1.938) | 0.217 |
Abbreviations: PND, permanent neurological dysfunction; NND, nonneurological dysfunction; OR, odds ratio; CI, confidence interval; SACP, selective antegrade cerebral perfusion; CPB, cardiopulmonary bypass.
Logistic regression model explaining probability difference between PND and TND
| Model by duration | Parameter | OR value | 95% CI |
|
|---|---|---|---|---|
| Whole operation | Age | 1.127 | (1.027–1.237) | 0.012 |
| ΔrSO2min | 0.901 | (0.844–0.963) | 0.002 | |
| Platelet | 0.994 | (0.983–1.006) | 0.311 | |
| Hemostasis time | 1.033 | (0.998–1.068) | 0.066 | |
| Female | 0.891 | (0.107–7.403) | 0.915 | |
| SACP | Age | 1.120 | (1.019–1.231) | 0.019 |
| ΔrSO2min | 0.907 | (0.850–0.967) | 0.003 | |
| Platelet | 0.990 | (0.978–1.003) | 0.117 | |
| Hemostasis time | 1.038 | (1.000–1.076) | 0.049 | |
| Female | 0.761 | (0.082–7.028) | 0.810 | |
| CPB | Age | 1.116 | (1.022–1.219) | 0.015 |
| ΔrSO2min | 0.906 | (0.849–0.968) | 0.003 | |
| Platelet | 0.994 | (0.982–1.005) | 0.286 | |
| Hemostasis time | 1.028 | (0.995–1.063) | 0.093 | |
| Female | 0.890 | (0.105–7.583) | 0.915 | |
| Hemostasis | Age | 1.092 | (1.005–1.187) | 0.039 |
| ΔrSO2min | 0.939 | (0.888–0.993) | 0.026 | |
| Platelet | 0.993 | (0.982–1.005) | 0.249 | |
| Hemostasis time | 1.031 | (0.998–1.064) | 0.067 | |
| Female | 1.191 | (0.157–9.046) | 0.866 |
Abbreviations: PND, permanent neurological dysfunction; TND, transient neurological dysfunction; OR, odds ratio; CI, confidence interval; SACP, selective antegrade cerebral perfusion; CPB, cardiopulmonary bypass.
Diagnostic performance indices of lowest relative rSO2 during each period in predicting PND
| Parameter | ΔrSO2min during | |||
|---|---|---|---|---|
| Whole surgery | SACP | CPB | Hemostasis | |
| Cut‐off value (%) | 79.7 | 81.6 | 80.8 | 78.6 |
| AUC | 0.708 | 0.720 | 0.697 | 0.662 |
| 95%CI | (0.557–0.858) | (0.570–0.870) | (0.554–0.840) | (0.492–0.831) |
| Sensitivity (%) | 55.3 | 75.3 | 57.6 | 80.7 |
| Specificity (%) | 84.6 | 69.2 | 84.6 | 50.0 |
|
| 0.016 | 0.011 | 0.023 | 0.071 |
Abbreviations: AUC, area under curve; CI, confidence interval; SACP, selective antegrade cerebral perfusion; CPB, cardiopulmonary bypass.
Figure 1ROC curves on PND for lowest rSO2 relative to baseline during the whole surgery (a), during SACP (b), during CPB (c), and during the hemostasis period (d)